{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:45:30Z","timestamp":1792752330231,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaad.2026.08.045","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:58:12Z","timestamp":1787065092000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ethical considerations of unapproved injectable peptides marketed for skin anti-aging"],"prefix":"10.1016","author":[{"given":"Jenny","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5913-9304","authenticated-orcid":false,"given":"Shari R.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2026.08.045_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.2026.10690","article-title":"Illicit injectable peptides and regulatory gaps","volume":"336","author":"Piatkowski","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2026.08.045_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2026.1790247","article-title":"Therapeutic peptides in gerontology: mechanisms and applications for healthy aging","volume":"7","author":"Mavrych","year":"2026","journal-title":"Front Aging"},{"issue":"22","key":"10.1016\/j.jaad.2026.08.045_bib3","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1001\/jama.2026.6388","article-title":"Under FDA, unapproved peptides likely to become more widely available","volume":"335","author":"Rubin","year":"2026","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.045_bib4","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jaad.2025.04.021","article-title":"Skincare ingredients recommended by cosmetic dermatologists: a Delphi consensus study","volume":"93","author":"Alvarez","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2026.08.045_bib5","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/ced.15301","article-title":"Combating social media misinformation in the dermatology clinic: practical advice","volume":"47","author":"Ouyang","year":"2022","journal-title":"Clin Exp Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226033621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226033621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:20:25Z","timestamp":1792750825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226033621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":5,"alternative-id":["S0190962226033621"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.045","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethical considerations of unapproved injectable peptides marketed for skin anti-aging","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}